Session Information
Date: Tuesday, November 10, 2026
Title: (2483-2518) Pediatric Rheumatology - Clinical Poster C
Session Type: Poster Session C
Session Time: 10:30AM-12:30PM
Background/Purpose: Autoimmune uveitis is a chronic, relapsing condition that carries risk of long-term visual impairment and often requires prolonged systemic immunosuppressive therapy (IMT). ACR guidelines recommend two years of sustained disease control before tapering therapy. Previous studies report high rates of relapse after treatment discontinuation. We aimed to evaluate the risk of uveitis relapse after discontinuation of systemic IMT in a pediatric cohort.
Methods: For this retrospective study, we used data from the Longitudinal Outcomes of Childhood Uveitis Study (LOCUS) registry and linked electronic health records to identify children with uveitis (ICD-10 diagnosis codes) who discontinued or tapered IMT after achieving uveitis quiescence. Inclusion criteria: 1) received IMT for at least 1 year; 2) had at least one ophthalmic exam in the year prior and one within the year following IMT discontinuation; and 3) had no ophthalmic exam indicating active uveitis in the year prior to IMT discontinuation. For patients with multiple IMT periods, only the first was considered. The primary outcome was active uveitis per Standardization of Uveitis Nomenclature (SUN) criteria. Patients were followed from the date of IMT discontinuation until uveitis relapse, re-initiation of systemic IMT, or 1 year of follow-up. Time to relapse was evaluated using Kaplan-Meier survival curves with log-rank testing, and exploratory comparisons between groups were performed using Wilcoxon rank-sum tests for continuous variables and Fisher’s exact tests for categorical variables.
Results: Our cohort included 25 patients with uveitis who discontinued IMT after at least 1 year of treatment and inactive uveitis (76% female; 88% white; median age at index: 8.3 years), of whom 24 (96%) had JIA (Table 1). Over 1 year of follow-up, 12 (48%) experienced relapse (median time: 108 days), and 8 (32%) remained relapse-free off IMT for 1 year (Figure 1). Of the remaining 5 patients, 2 restarted IMT due to arthritis relapse, 1 changed IMT due to intolerance, and 2 were still tapering. No significant difference in survival was observed by IMT treatment regimen (p=0.36; Figure 2). Additionally, there were no significant differences in age at index, age at initial uveitis diagnosis, or duration of IMT therapy between patients who relapsed and those who remained relapse-free at 1 year (p=0.53, 0.48, 0.12, respectively; Table 1).
Conclusion: Consistent with prior studies, children with autoimmune uveitis face a substantial risk of relapse within 1 year of discontinuing systemic IMT, supporting cautious IMT withdrawal and close monitoring after discontinuation. Further research is needed to identify predictors of sustained remission and guide strategies for treatment tapering and discontinuation in pediatric uveitis.
Table 1. Cohort demographic and clinical characteristics. P-values were derived from Wilcoxon rank-sum tests for continuous variables and Fisher’s exact tests for categorical variables. IQR: inter-quartile range
Figure 1. Swimmer plot of medication and ophthalmic exam history during follow-up for patients with inactive disease at time of immunosuppressive therapy (IMT) discontinuation.
Figure 2. Survival curves by immunosuppressive therapy (IMT) group for patients with inactive disease at IMT discontinuation. P-value was dervied from log-rank testing.
To cite this abstract in AMA style:
Hartlage C, Wagner M, Vennemeyer S, Duell A, Utz V, Quinlan-Waters M, Angeles-Han S. Examining the Risk of Pediatric Uveitis Relapse After Discontinuation of Long-Term Systemic Immunosuppressive Therapy in a Retrospective Cohort [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/examining-the-risk-of-pediatric-uveitis-relapse-after-discontinuation-of-long-term-systemic-immunosuppressive-therapy-in-a-retrospective-cohort/. Accessed .ACR Meeting Abstracts - https://acrabstracts.org/abstract/examining-the-risk-of-pediatric-uveitis-relapse-after-discontinuation-of-long-term-systemic-immunosuppressive-therapy-in-a-retrospective-cohort/
